Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 1/20 | 0.70 |
| ▸ | CHKA | P35790 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | HBB | P68871 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL10432272 | 0.98 | CHRM5 (0.67) | CHRM5CHKAMAPTSMN1; SMN2TSHR | |
| Toluene SCHEMBL2454660 | 0.89 | CHRM5 (0.55) | CHRM5CHKAMAPTSMN1; SMN2TSHR | |
| SCHEMBL6199563 | 0.89 | CHRM5 (0.80) | CHRM5CHKAMAPTSMN1; SMN2TSHR | |
| Benzene SCHEMBL28113160 | 0.89 | CHRM5 (0.89) | CHRM5CHKAMAPTSMN1; SMN2TSHR | |
| Pyridine SCHEMBL1830428 | 0.84 | CHRM5 (0.80) | CHRM5CHKAMAPTSMN1; SMN2TSHR | |
| Toluene SCHEMBL28313052 | 0.84 | ALDH1A1 (0.65) | CHRM5CHKASMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL8664726 | 0.83 | CHRM5 (1.00) | CHRM5CHKAMAPTSMN1; SMN2TSHR | |
| SCHEMBL189 | 0.83 | — | — | |
| Phosphine SCHEMBL23270013 | 0.81 | CHRM5 (0.94) | CHRM5CHKAMAPTSMN1; SMN2TSHR | |
| Hydrochloric Acid SCHEMBL9013636 | 0.81 | CHRM5 (0.94) | CHRM5CHKAMAPTSMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108129385-B | Composite quaternary ammonium salt nonlinear optical crystalline material and preparation method thereof | 华南农业大学 | 2020-01-14 | — | — | CN | claimed |
| CN-108129385-B | Composite quaternary ammonium salt nonlinear optical crystalline material and preparation method thereof | 华南农业大学 | 2020-01-14 | — | — | CN | disclosed |
| CN-108129385-B | Composite quaternary ammonium salt nonlinear optical crystalline material and preparation method thereof | 华南农业大学 | 2020-01-14 | — | — | CN | disclosed |
| CN-105451772-A | Polydendrons | UNIV LIVERPOOL | 2016-03-30 | — | — | CN | disclosed |
| CN-103124759-B | Functional biodegradable polymers | UNIV AKRON | 2015-03-25 | — | — | CN | disclosed |
| US-20100145018-A1 | Lipid-Polymer-Conjugates | ASTELLAS PHARMA EUROPE BV (NL) | 2010-06-10 | — | — | US | disclosed |
| EP-1392755-B1 | LIPID-POLYMER-CONJUGATES COMPOSITIONS | ASTELLAS PHARMA EUROP B V (NL) | 2008-12-03 | — | — | EP | disclosed |
| US-20040254352-A1 | Lipid-polymer-conjugates | YAMANOUCHI EUROPE B.V. (NL) | 2004-12-16 | — | — | US | disclosed |
| EP-1392756-A2 | LIPID-POLYMER-CONJUGATES | Yamanouchi Europe B.V. (NL) | 2004-03-03 | — | — | EP | disclosed |
| EP-1392755-A1 | LIPID-POLYMER-CONJUGATES COMPOSITIONS | YAMANOUCHI EUROPE B.V. (NL) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002098951-A2 | LIPID-POLYMER-CONJUGATES | YAMANOUCHI EUROPE B.V. (NL) | 2002-12-12 | — | — | WO | disclosed |
| WO-2002098952-A1 | LIPID-POLYMER-CONJUGATES COMPOSITIONS | YAMANOUCHI EUROPE B.V. (NL) | 2002-12-12 | — | — | WO | disclosed |
| CN-1281355-A | Biodegradable mixed polymeric micelles for gene delivery | SAM YANG CO (KR) | 2001-01-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100145018-A1 | Lipid-Polymer-Conjugates | PARG, GLUL, PHOSPHO1 | CHRM5 4698/4885CHKA 854/4885MAPT 1792/4885 |
| US-20040254352-A1 | Lipid-polymer-conjugates | PARG, GLUL, PARN | CHRM5 4685/4885CHKA 798/4885MAPT 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.